Cibus, Inc. (CBUS) Q3 2025 Earnings Call

Investor webinar replay

Replay transcript excerpt

Please stand by. We're about to begin. Good afternoon, everyone, and welcome to the CBIS third quarter 2025 results conference call. All participants will be in a listen-only mode. After today's presentation, there will be an opportunity to ask questions. And please note, today's conference is being recorded. At this time, I would like to turn the conference over to Mr. Carlo Bruce, Chief Financial Officer. Sir, please go ahead. Thank you and good afternoon. I would like to thank you for taking time to join us for CBIS third quarter 2025 financial results and business update conference call and webcast. Presenting with me today is Peter Beethem, co-founder, interim chief executive officer, president and COO, and Greg Gochel, co-founder and our chief scientific officer. Before we begin the call, I'd like to remind everyone that statements made on the call and webcast including those regarding future financial results and future operational goals and industry prospects are forward-looking and may be subject to a number of risks and uncertainties that could cause actual results to differ materially from those described in the call. Please refer to CBUS SAC filings for a list of associated risks. This conference call is being webcast. The webcast link along with our press release and corporate presentation, are available on the investor relations section of cbus.com to assist you in your analysis of our business. And with that, I would now like to turn the call over to Peter. Thanks, Carlo. And good afternoon, everyone. This past quarter has further focused our commercialization and production activities. I clearly see our company as a coiled spring ready to deliver gene editor traits for years to come. Today, I am excited to share the significant commercialization momen...